IDOVEN

Idoven has developed the world’s first cardiology-as-a-service platform powered by artificial intelligence that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale. The company counts partners such as AstraZeneca, Abbott, and GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation. Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. CB Insights have also selected Idoven as one of the top 50 companies in Digital Health for 2023

IDOVEN headquartered in Europe, operates in the Software, Artificial Intelligence (AI), Machine Learning, PaaS, Health Care, Personal Health sector. The company focuses on Software and has secured $4.1B in funding across 168 round(s). With a team of 11-50 employees, IDOVEN is actively contributing to advancements in Software. Their latest funding round, Venture Round - IDOVEN, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.